Phase I study of GS7836 in patients with advanced incurable solid tumours.
Phase of Trial: Phase I
Latest Information Update: 29 May 2014
At a glance
- Drugs Thiarabine (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 29 Oct 2009 Planned end date (17 Feb 2004) added as reported by National Cancer Institute of Canada.
- 10 Feb 2006 New trial record.